New York Cannabis Is Booming. So Why Does It Feel Like a Race to the Bottom?
New York cannabis sales are surging, but average prices are falling and competition is intensifying. From Revelry to Hall of Flowers, the industry’s biggest challenge isn’t generating hype. It’s …
CropPak Launches Marijuana Packaging Business and New Website for Cannabis Growers
CropPak has launched a new custom cannabis packaging business and website serving growers and brands across Canada and the United States. Abbotsford, British Columbia–(Newsfile Corp. -) – CropPak has …
How the fight over unionization is becoming a battle over N.J.’s billion-dollar legal weed industry
A Jersey City cannabis dispensary is challenging New Jersey’s cannabis labor law in federal court, alleging the state’s union requirements have created a one-union monopoly.
The Deep Value Play for Growth Investors Isn’t Artificial Intelligence, It’s This Forgotten Industry
Investing in artificial intelligence (AI) stocks has been all the rage in recent years. Nvidia, Palantir Technologies, and Broadcom have been among the most popular investments due to their impressive …
What a Highly Regulated Industry Taught Me About Leadership
Eight years ago, the “green rush” of the U.S. legal cannabis industry was in full swing. States like Washington, Oregon, and Colorado had already legalized and commercialized adult use and California …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
What the Trump administration’s move to reclassify marijuana means for investors
The Department of Justice said it will immediately move FDA-approved marijuana from Schedule I to Schedule III under the Controlled Substances Act.
Cannabis stocks lose buzz despite this landmark decision
Cannabis stocks rose Thursday after the Trump administration, in a landmark decision, reclassified marijuana as a less-dangerous drug. But early stock gains faded. Marijuana now goes from being …
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to …
How does marijuana rescheduling affect cannabis companies now?
Some operators are seeking partnerships for clinical studies, while others are developing strategies to scale their operations.
Global CBD Skin Care Market Projected to Reach USD 58.1 Billion by 2036 Driven by Innovation and Premiumization
The global CBD skincare market will expand from USD 6.6 billion in 2026 to USD 58.1 billion by 2036 | Future Market Insights, Inc. NEWARK, DE / ACCESS Newswire / February 9, 2026 / The global CBD skin …
TruFull CBD Gummies: Product Disclosure Information Updated as CBD Supplement Research Grows in 2026
Examining hemp-derived CBD supplement disclosures, third-party testing verification, THC-free claims, ingredient transparency, refund policies, and what consumers evaluate when researching …
TruFull CBD Gummies | Launch “CBD Gummies Safe Relieves Anxiety Effective Reduces Pain & Stress With TruFull CBD 2026
A trusted, hemp-based CBD supplement created to help manage stress, and support physical comfort safely.New York City, Feb. 04, 2026 (GLOBE NEWSWIRE) — In today’s fast-paced lifestyle, stress, poor …
High Tide Inc. (HITI): Among high growth Canadian stocks to buy
We recently published an article titled 9 High Growth Canadian Stocks to Buy. High Tide Inc. (NASDAQ:HITI), founded in 2009, is Canada’s largest cannabis retailer and the country’s highest …
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
Gregory D. Gorgas, Chief Executive Officer of Artelo, added, “ART12.11 was purpose-built to meet the standards required for federal healthcare integration and prescription-based use, and we believe it …
Recent Comments